Pomalidomide-NH-PEG3-azide
Pomalidomide-NH-PEG3-azide Basic information
- Product Name:
- Pomalidomide-NH-PEG3-azide
- Synonyms:
-
- Pomalidomide-NH-PEG3-azide
- IUN-36463
- 4-((2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
- Pomalidomide 4'-PEG3-azide
- 1H-Isoindole-1,3(2H)-dione, 4-[[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethyl]amino]-2-(2,6-dioxo-3-piperidinyl)-
- 4-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
- CAS:
- 2271036-46-3
- MF:
- C21H26N6O7
- MW:
- 474.47
- Mol File:
- 2271036-46-3.mol
Pomalidomide-NH-PEG3-azide Chemical Properties
- form
- Solid
- color
- Light yellow to yellow
Pomalidomide-NH-PEG3-azide Usage And Synthesis
Uses
Pomalidomide 4'-PEG3-azide is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide-based cereblon ligand and a linker. Pomalidomide 4'-PEG3-azide can be used for the synthesis of iRucaparib-TP3 (Compound 3). iRucaparib-TP3 is a highly efficient PARP1?degrader based on Rucaparib by using the PROTAC approach[1]. Pomalidomide 4'-PEG3-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
IC 50
Cereblon
storage
Store at -20°C
References
[1] Shuai Wang, et al. Uncoupling of PARP1 trapping and inhibition using selective PARP1 degradation. Nat Chem Biol. 2019 Dec;15(12):1223-1231. DOI:10.1038/s41589-019-0379-2
Pomalidomide-NH-PEG3-azideSupplier
- Tel
- 021-61469567 13482353728
- sales@fdc-chemical.com
- Tel
- +86-156-80926068 +86-15680926068
- 1924344760@qq.com
- Tel
- 13504435624
- 1927928688@qq.com
- Tel
- 025-86755008 17751752005
- hszhang@bestfluorodrug.com
- Tel
- 400-8210725 4008210725
- malulu@leyan.com
Pomalidomide-NH-PEG3-azide(2271036-46-3)Related Product Information
- Pomalidomide-NH-PEG2-azide
- Pomalidomide-NH-PEG6-azide
- Pomalidomide-PEG4-azide
- Pomalidomide-NH-PEG1-azide
- Pomalidomide-NH-PEG5-azide
- 1H-Isoindole-1,3(2H)-dione, 4-[(3-azidopropyl)amino]-2-(2,6-dioxo-3-piperidinyl)-
- Propanoic acid, 3-[2-[2-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]-, 2,2,2-trifluoroacetate (1:1)
- 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl]amino]-
- 4-((2-(2-(2-azidoethoxy)ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
- Poma-NH-C4-N3
- 4-((6-azidohexyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
- Propanoic acid, 3-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethoxy]-, 2,2,2-trifluoroacetate (1:1)
- POMALIDOMIDE-PEG2-CO2H
- Pomalidomide-PEG4-CO2H
- Propanoic acid, 3-[2-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethoxy]ethoxy]-, 2,2,2-trifluoroacetate (1:1)
- 4-((5-azidopentyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
- Pomalidomide-PEG3-CO2H
- 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-(2-hydroxyethoxy)ethyl]amino]-